About email@example.comThis author has not yet filled in any details.
So far firstname.lastname@example.org has created 20 blog entries.
ErVaccine Technologies Announces Inaugural Members of Scientific Advisory Board
Download the press release Lyon, France – February 23, 2023 [...]
ErVaccine closes a €4.5 million financing round and prepares to start clinical trial with its first therapeutic cancer vaccine in 2023
ErVaccine is developing a therapeutic vaccine and cell therapy technology [...]
Neoantigen Based Therapies Summit 2022 – Boston
Paola Bonaventura, project leader at ErVaccine Technologies, has been giving [...]
INCIT 2022 congress – Nantes, FR
Stéphane Depil, founder and CEO of ErVaccine Technologies, will give [...]
ErVaccine and Centre Leon Berard collaborative project selection by French ANR
ErVaccine Technologies, in collaboration with Centre Leon Berard hospital / [...]
ErVaccine Technologies is hiring a bioinformatician
Download the job offer SENIOR COMPUTATIONAL BIOLOGIST POSITION Background ErVaccine [...]
ErVaccine Technologies announces the publication of a new paper in American Journal of Hematology
ErVaccine Technologies, a preclinical-stage biotechnology company, announces the publication of [...]